Dotz Nano Limited
0.02
AUD
0.00
(0.00%)
Dotz Nano Limited
ASX:DTZ
(Australian Securities Exchange)
Recent
price
0.02
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
USD
•
in mil. unless spec.Working Capital
USD
•
in mil. unless spec.Growth Rates
USD
•
in mil. unless spec.Semi-annual Revenue
USD
•
in mil. unless spec.Semi-annual Earnings Per Share
USD
•
in mil. unless spec.Semi-annual Dividends Per Share
USD
•
in mil. unless spec.- Similar Companies
- Business
- Dotz Nano Limited (ASX: DTZ) develops and commercializes nanotechnology-based security inks, markers, and authentication technologies for anti-counterfeiting, traceability, and brand protection applications. The company offers proprietary products including NanoInk for covert marking on documents and products; NanoTag for forensic-level authentication using smartphone-readable fluorescent markers; and DotzCode for scalable serialization and supply chain tracking via proprietary nano-particles; alongside services such as custom marker development, integration consulting, and verification software platforms. Dotz Nano operates primarily in the security and authentication sector, targeting industries like pharmaceuticals, luxury goods, consumer packaged goods, and government documents, with global customer deployments across Europe, North America, Asia-Pacific, and Australia [ from earlier][ from earlier]. Founded in 2007 and headquartered in Melbourne, Australia, the company maintains research and development facilities in Australia and sales offices in the United States and Europe, with no disclosed parent company or major subsidiaries. Dotz Nano's technologies leverage patented silica-based nano-particles that enable machine-readable covert features undetectable to the naked eye but verifiable through low-cost readers or mobile apps [ from earlier]. In the past two years, Dotz Nano has pursued strategic expansions including a 2024 distribution partnership with a leading European anti-counterfeiting firm to broaden NanoInk adoption in luxury packaging; completion of a A$10 million funding round in late 2024 led by institutional investors to accelerate commercialization of DotzCode serialization software; and the launch of an enhanced NanoTag verifier app in mid-2025 supporting AI-driven authentication for pharmaceutical supply chains. The company also announced a manufacturing scale-up agreement with a U.S.-based partner in early 2025 to increase production capacity for North American markets, alongside pilot projects with two major consumer goods brands for traceability solutions [ from earlier].